pharma · Anal Neoplasm · Lassa Fever · INO
INOVIO Pharmaceuticals
INOVIO PHARMACEUTICALS, INC.
INOVIO Pharmaceuticals is a pharma organization headquartered in Plymouth Meeting, USA. It trades on NYSE under ticker INO. Primary therapeutic focus areas include Anal Neoplasm, Lassa Fever, Prostate Cancer, Chronic Hep
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US HQ
203 Employees
Public company Type
INO · NYSE Ticker
Company details
- Status
- Public
- HQ
- 660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US
- Employees
- 203
- Programs
- 46
- Drugs
- 8
- Patents
- 75
INO-4201
Phase 1 · mab · Ebola Virus Disease
INO-4201 for Ebola Virus Disease is a Phase 1 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Internal code 2020-02774
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- INOVIO PHARMACEUTICALS, INC.
- Phase
- Phase 1
- Modality
- mab
- Indication
- Ebola Virus Disease
- Status
- completed
- Trials
- 1